Association of birthweight and penetrance of diabetes in individuals with HNF4A-MODY: a cohort study
Medienart: |
Artikel |
---|
Erscheinungsjahr: |
2021 |
---|---|
Erschienen: |
2021 |
Enthalten in: |
Zur Gesamtaufnahme - volume:65 |
---|---|
Enthalten in: |
Diabetologia - 65(2021), 1 vom: 07. Okt., Seite 246-249 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Locke, Jonathan M. [VerfasserIn] |
---|
Links: |
Volltext [lizenzpflichtig] |
---|
Themen: |
Birthweight |
---|
RVK: |
---|
Anmerkungen: |
© The Author(s) 2021 |
---|
doi: |
10.1007/s00125-021-05581-6 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
OLC2077609923 |
---|
LEADER | 01000caa a22002652 4500 | ||
---|---|---|---|
001 | OLC2077609923 | ||
003 | DE-627 | ||
005 | 20230518111411.0 | ||
007 | tu | ||
008 | 221220s2021 xx ||||| 00| ||eng c | ||
024 | 7 | |a 10.1007/s00125-021-05581-6 |2 doi | |
035 | |a (DE-627)OLC2077609923 | ||
035 | |a (DE-He213)s00125-021-05581-6-p | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
082 | 0 | 4 | |a 610 |q VZ |
082 | 0 | 4 | |a 610 |q VZ |
084 | |a XA 40615 |q VZ |2 rvk | ||
100 | 1 | |a Locke, Jonathan M. |e verfasserin |0 (orcid)0000-0001-9516-5251 |4 aut | |
245 | 1 | 0 | |a Association of birthweight and penetrance of diabetes in individuals with HNF4A-MODY: a cohort study |
264 | 1 | |c 2021 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ohne Hilfsmittel zu benutzen |b n |2 rdamedia | ||
338 | |a Band |b nc |2 rdacarrier | ||
500 | |a © The Author(s) 2021 | ||
650 | 4 | |a Birthweight | |
650 | 4 | |a Hepatocyte nuclear factor-4 alpha (HNF4A) | |
650 | 4 | |a Maturity-onset diabetes of the young (MODY) | |
650 | 4 | |a Penetrance | |
700 | 1 | |a Dusatkova, Petra |0 (orcid)0000-0002-8647-9088 |4 aut | |
700 | 1 | |a Colclough, Kevin |0 (orcid)0000-0003-0566-4853 |4 aut | |
700 | 1 | |a Hughes, Alice E. |0 (orcid)0000-0003-1352-4447 |4 aut | |
700 | 1 | |a Dennis, John M. |0 (orcid)0000-0002-7171-732X |4 aut | |
700 | 1 | |a Shields, Beverley |0 (orcid)0000-0003-3785-327X |4 aut | |
700 | 1 | |a Flanagan, Sarah E. |0 (orcid)0000-0002-8670-6340 |4 aut | |
700 | 1 | |a Shepherd, Maggie H. |0 (orcid)0000-0003-2660-0955 |4 aut | |
700 | 1 | |a Dempster, Emma L. |0 (orcid)0000-0003-1257-5314 |4 aut | |
700 | 1 | |a Hattersley, Andrew T. |0 (orcid)0000-0001-5620-473X |4 aut | |
700 | 1 | |a Weedon, Michael N. |0 (orcid)0000-0002-6174-6135 |4 aut | |
700 | 1 | |a Pruhova, Stepanka |0 (orcid)0000-0001-8019-8026 |4 aut | |
700 | 1 | |a Patel, Kashyap A. |0 (orcid)0000-0002-9240-8104 |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Diabetologia |d Springer Berlin Heidelberg, 1965 |g 65(2021), 1 vom: 07. Okt., Seite 246-249 |w (DE-627)129069140 |w (DE-600)1694-9 |w (DE-576)014400847 |x 0012-186X |7 nnns |
773 | 1 | 8 | |g volume:65 |g year:2021 |g number:1 |g day:07 |g month:10 |g pages:246-249 |
856 | 4 | 1 | |u https://doi.org/10.1007/s00125-021-05581-6 |z lizenzpflichtig |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a SYSFLAG_A | ||
912 | |a GBV_OLC | ||
912 | |a SSG-OLC-PHA | ||
912 | |a SSG-OLC-DE-84 | ||
912 | |a GBV_ILN_267 | ||
912 | |a GBV_ILN_2018 | ||
912 | |a GBV_ILN_4277 | ||
936 | r | v | |a XA 40615 |
951 | |a AR | ||
952 | |d 65 |j 2021 |e 1 |b 07 |c 10 |h 246-249 |